Polaris Logo - v2.png
Caprolactam Market Size is Projected to be US$ 33.97 Billion by 2032, at a CAGR of 4.7% from 2024 to 2032 | Polaris Market Research
September 20, 2024 08:15 ET | Polaris Market Research & Consulting LLP
New York, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Market Overview: The caprolactam market was estimated at USD 22.55 billion in 2023. The market valuation is expected to be USD 33.97 billion by...
Polaris Logo - v2.png
Capacitive Sensors Market Set for Robust Expansion, Projected Value of USD 48.05 Billion by 2032 at 4.9% CAGR | Polaris Market Research
September 20, 2024 08:10 ET | Polaris Market Research & Consulting LLP
New York, USA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Market Overview: The global capacitive sensors market was valued at USD 31.35 billion in 2023 and is poised to grow from USD 32.76 billion in...
Pfizer und BioNTech
Pfizer und BioNTech erhalten positive CHMP-Empfehlung für an Omikron KP.2 angepassten COVID-19-Impfstoff in der Europäischen Union
September 20, 2024 08:10 ET | BioNTech SE
Der an Omikron KP.2 angepasste COVID-19-Impfstoff wird nach Zulassung durch die Europäische Kommission für Personen ab 6 Monaten verfügbar seinDaten zeigten, dass der an Omikron KP.2 angepasste...
Pfizer and BioNTech
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
September 20, 2024 08:10 ET | BioNTech SE
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron...
urgently.png
Urgently Completes Strategic Divestiture of The Floow in Support of Core Business Focus
September 20, 2024 08:00 ET | Urgent.ly Inc.
VIENNA, Va., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Urgent.ly, Inc. (Nasdaq: ULY) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today...
Original.png
Global Engine Group Holding Limited Announces Pricing of $8 Million Initial Public Offering
September 20, 2024 08:00 ET | Global Engine Group Holding Limited
Hong Kong, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Global Engine Group Holding Limited (the “Company” or “GLE”), a Hong Kong-headquartered integrated solutions provider in information communication...
Logo.png
Dr. Carlo Papa Appointed to Board of Directors of Odysight.ai
September 20, 2024 08:00 ET | Odysight.ai Inc.
OMER, Israel, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Odysight.ai Inc. (OTCQB: ODYS), a pioneer in AI driven Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the...
sintx_grn_blk@4x-8.png
Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”
September 20, 2024 08:00 ET | SINTX Technologies, Inc.
Salt Lake City, Utah, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) a leader in advanced ceramics, and Prodways, a global specialist in 3D...
logo.jpg
Samsung Bioepis and Biogen Receive Positive CHMP Opinion for Aflibercept Biosimilar, OPUVIZ™
September 20, 2024 08:00 ET | Samsung Bioepis
OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency ...
KASKELA LAW LOGO1.jpg
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm
September 20, 2024 08:00 ET | Kaskela Law
PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company’s long-term...